Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30209466 | 1.00 | ALOX5 (0.73) | ALOX5HDAC6 | |
| SCHEMBL6440984 | 1.00 | ALOX5 (0.73) | ALOX5HDAC6 | |
| SCHEMBL8892800 | 0.89 | ALOX5 (0.78) | ALOX5HDAC6 | |
| SCHEMBL9315247 | 0.88 | ALOX5 (0.80) | ALOX5HDAC6 | |
| SCHEMBL9303393 | 0.87 | ALOX5 (0.75) | ALOX5HDAC6 | |
| SCHEMBL8895036 | 0.87 | ALOX5 (0.75) | ALOX5HDAC6 | |
| SCHEMBL9301897 | 0.86 | ALOX5 (0.77) | ALOX5HDAC6 | |
| SCHEMBL8892164 | 0.86 | ALOX5 (0.75) | ALOX5HDAC6 | |
| SCHEMBL9431826 | 0.86 | ALOX5 (0.80) | ALOX5HDAC6 | |
| SCHEMBL8827857 | 0.86 | ALOX5 (0.80) | ALOX5HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0637961-A4 | METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE WITH LEUKOTRIENE SYNTHESIS INHIBITORS. | MILES INC (US) | 1995-08-09 | — | — | EP | claimed |
| EP-0637961-A1 | METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE WITH LEUKOTRIENE SYNTHESIS INHIBITORS | Bayer Corporation (US) | 1995-02-15 | — | — | EP | claimed |
| WO-1994018976-A1 | METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE WITH LEUKOTRIENE SYNTHESIS INHIBITORS | MILES INC. (US) | 1994-09-01 | — | — | WO | claimed |
| JP-6192228-A | — | — | None | — | — | JP | disclosed |
| JP-6192228-A | — | — | None | — | — | JP | disclosed |
| US-20050222193-A1 | Novel combination for the treatment of airway disorders | ALTANA PHARMA AG (DE) | 2005-10-06 | — | — | US | disclosed |
| WO-2005074932-A1 | THE USE OF (S) - PANTOPRAZOLE MAGNESIUM FOR THE TREATMENT OF AIRWAY DISORDERS | ALTANA PHARMA AG (DE) | 2005-08-18 | — | — | WO | disclosed |
| US-20050165041-A1 | Combination for the treatment of airway disorders | ALTANA PHARMA AG (DE) | 2005-07-28 | — | — | US | disclosed |
| EP-1517706-A2 | COMBINATION OF A PROTON PUMP INHIBITOR AND A RESPIRATORY AGENT FOR THE TREATMENT OF RESPIRATORY DISEASES | ALTANA Pharma AG (DE) | 2005-03-30 | — | — | EP | disclosed |
| EP-1506016-A2 | NEW COMBINATION OF REVERSIBLE PROTON PUMP INHIBITORS AND AIRWAY THERAPEUTICS FOR TREATING AIRWAY DISORDERS | ALTANA Pharma AG (DE) | 2005-02-16 | — | — | EP | disclosed |
| WO-2003094967-A2 | NEW COMBINATION OF REVERSIBLE PROTON PUMP INHIBITORS AND AIRWAY THERAPEUTICS FOR TREATING AIRWAY DISORDERS | ALTANA PHARMA AG (DE) | 2003-11-20 | — | — | WO | disclosed |
| WO-2003094968-A2 | COMBINATION OF A PROTON PUMP INHIBITOR AND A RESPIRATORY AGENT FOR THE TREATMENT OF RESPIRATORY DISEASES | ALTANA PHARMA AG (DE) | 2003-11-20 | — | — | WO | disclosed |
| EP-0637961-A4 | METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE WITH LEUKOTRIENE SYNTHESIS INHIBITORS. | MILES INC (US) | 1995-08-09 | — | — | EP | disclosed |
| US-5391555-A | Administering 2-(4(2-quinolinyl-methoxy)-phenyl)-acetic acid derivatives; Crohn's disease | MILES INC. (US) | 1995-02-21 | — | — | US | disclosed |
| EP-0637961-A1 | METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE WITH LEUKOTRIENE SYNTHESIS INHIBITORS | Bayer Corporation (US) | 1995-02-15 | — | — | EP | disclosed |
| WO-1994018976-A1 | METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE WITH LEUKOTRIENE SYNTHESIS INHIBITORS | MILES INC. (US) | 1994-09-01 | — | — | WO | disclosed |
| JP-H06192228-A | CRYSTALLINE (R)-(-)-2-XYCLOHEPTYL-N-METHYLSULFONYL-(4-(2-QUINOLINYLMETHOXY)-PHENYL)-ACETOAMIDE | BAYER AG | 1994-07-12 | — | — | JP | disclosed |
| JP-H06192228-A | CRYSTALLINE (R)-(-)-2-XYCLOHEPTYL-N-METHYLSULFONYL-(4-(2-QUINOLINYLMETHOXY)-PHENYL)-ACETOAMIDE | BAYER AG | 1994-07-12 | — | — | JP | disclosed |
| EP-0593976-A1 | Crystalline (R)-(-)-2-cycloheptyl-N-methylsulfonyl-4-(2-quinolinyl-methoxy)-phenyl-acetamide | BAYER AG (DE) | 1994-04-27 | — | — | EP | disclosed |
| EP-0593976-A1 | Crystalline (R)-(-)-2-cycloheptyl-N-methylsulfonyl-4-(2-quinolinyl-methoxy)-phenyl-acetamide | BAYER AG (DE) | 1994-04-27 | — | — | EP | disclosed |